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Polyhexamethylene biguanide (PHMB), a broad spectrum disinfectant against many pathogens, was used as a
stabilizing ligand for the synthesis of fairly uniform silver nanoparticles. The particles formed were characterized
using UV-visible spectroscopy, FTIR, dynamic light scattering, electrophoretic mobility, and TEM to measure their
morphology and surface chemistry. PHMB-functionalized silver nanoparticles were then evaluated for their
antimicrobial activity against a gram-negative bacterial strain, Escherichia coli. These silver nanoparticles were found
to have about 100 times higher bacteriostatic and bactericidal activities, compared to the previous reports, due to
the combined antibacterial effect of silver nanoparticles and PHMB. In addition to other applications, PHMB-
functionalized silver nanoparticles would be extremely useful in textile industry due to the strong interaction of
PHMB with cellulose fabrics.
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Antimicrobial activity of silver nanoparticles (Ag NPs) is
well documented, and they are currently being used in a
variety of commercial antimicrobial products including
textile products and paints etc. [1-6]. Although the
mechanism of their antimicrobial activity is not com-
pletely understood yet, silver, whether in the form of
ionic or metallic state, is known to destabilize and in-
crease the permeability of bacterial membranes [7]. It
results in the collapse of the plasma membrane poten-
tial, disruption of ion transport processes, and the de-
pletion of the levels of intracellular ATP [8-10]. Silver
also inactivates essential respiratory enzymes and pro-
teins responsible for RNA and DNA replication in bac-
teria [7,11,12]. Ag NPs can penetrate inside the
microbial cells, damaging sulfur and phosphorus con-
taining compounds such as DNA and proteins [9,13-
15]. Although Ag NPs form complexes with various* Correspondence: ihussain@lums.e du.pk
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in any medium, provided the original work is pamino acids to inhibit protein's function, their toxicity
to the mammalian cells is very limited, thus, warranting
their antimicrobial applications in medical and health-
care products [16-20].
Due to the growing interest in the use of Ag NPs to
develop antimicrobial products, various methods are
being developed for their preparation with a fair con-
trol over their size, shape, and the surface chemistry
[5,21-26]. Recent studies have shown that antimicrobial
properties of Ag NPs are significantly affected by their
nanoscale dimensions (size and shape) and the surface
ligands/charge, and thus, the efforts are being made to
produce Ag NPs with the highest possible antimicrobial
properties to minimize the load of nanoparticles in any
commercial products without compromising their anti-
microbial activity [5,21-26]. One such elegant approach
has recently been reported to integrate the antimicro-
bial properties of an enzyme, lysozyme, with those of
silver nanoparticles, and the resulting hybrid nanoparti-
cles showed improved microbial toxicity over other
preparations [27]. In order to increase the repertoire of
effective antimicrobial products, we have now inte-
grated the antimicrobial property of polyhexamethylenen Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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and to the best of our knowledge, the antimicrobial ac-
tivity of these hybrid silver nanoparticles is much
higher than the previous reports. PHMB is a positively
charged polymer having polymeric biguanide units in
the backbone of its structure [−(CH2)6.NH.C(=NH).
NH.C(=NH).NH-]n, where n ranges from 2 to 40 hav-
ing an average value of 11 [28]. It is being used in
medicine [29-35], textile, and food industry [36,37] as
an antiseptic agent since many years due to its broad
spectrum antibacterial effect. PHMB acts as a bacterio-
static if administered at low concentrations, i.e., from 1
to 10 μg/mL and as bactericidal at high doses, i.e.,
≥10 μg/mL [38-40]. It damages the membrane integrity
by nonspecifically interacting with acidic lipid residues
of cytoplasmic membrane [41,42]. PHMB also affects
nucleic acids due to its strong interaction with them
causing structural and functional changes in the micro-
bial genome [43]. Keeping in view the widespread anti-
microbial applications of PHMB, we set out to coat it
on silver nanoparticles to develop a hybrid product
with enhanced antimicrobial properties. Using Escheri-
chia coli as a model microorganism, the bacteriostatic
and bactericidal concentrations of these cationic hybrid
silver nanoparticles were found to be 0.075 and
0.15 μg/mL, respectively, which are much higher than
the previous reports on silver nanoparticles. Figure 1
shows a simple cartoon to demonstrate the antibacter-
ial activity of PHMB-functionalized silver nanoparticles.Figure 1 The interaction of PHMB-functionalized silver nanoparticlesMethods
PHMB (20%w/v) was purchased from Arch Chemicals
(Norwalk, CT, USA). All other chemicals were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA), ex-
cept tryptone, agar, and yeast extract which were
purchased from MP Biomedicals (Santa Ana, CA, USA),
and were used as received without further purification.
Pure strain of E. coli was provided by Invitrogen
(Carlsbad, CA, USA). Luria Bertani (LB) medium, used
for the growth study of E. coli, was prepared using 1%
tryptone, 0.5% yeast extract, and 1% sodium chloride in
water, and pH was adjusted to 7 using 0.5 M solution of
sodium hydroxide and hydrochloric acid. Ultrapure
water with a resistivity of 18.2 MΩ cm was used as the
solvent in all preparations.
Synthesis of Ag NPs
In a typical experiment to prepare PHMB functionalized
Ag NPs, a given volume of PHMB aqueous solution,
starting from 0.5 to 200 μg/mL (ideally, 15 mL, 20 μg/
mL), was added to an aqueous solution of AgNO3
(25 mL, 1 mM) under vigorous stirring. The reaction
mixture was stirred vigorously for 2 h to let PHMB form
a complex with silver. Freshly prepared aqueous solution
of sodium borohydride (5 mL, 0.8 mg/mL) was then
added quickly to PHMB-Ag solution, and the reaction
was allowed to complete for 5 h. The yellow/brownish
suspension of silver nanoparticles was then filter purified
to remove excess PHMB and other impurities usingwith the bacteria to demonstrate their antibacterial activity.
Figure 2 UV-visible absorption spectra of silver nanoparticles
produced using different concentrations of PHMB. The inset
shows the optical image of dispersed silver nanoparticles.
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Millipore Corporation, Billerica, MA, USA ) having a
molecular weight cutoff value of 30 KDa and then stored
at room temperature for further analysis and use in sub-
sequent experiments.
Antimicrobial activity of PHMB-functionalized Ag NPs
In order to study the effect of PHMB-stabilized Ag NPs
on bacterial growth, E. coli strain was grown on an agar
plate, and its fresh colony was transferred with the help
of a sterilized loop into a shake flask which was then
incubated in an incubator shaker for 12 h at 37°C at a
shaking speed of 150 rpm under aerobic conditions. The
growth of bacteria was measured by taking optical dens-
ity (OD) of samples at 600 nm. When the OD of growth
culture approached 1 at 600 nm, the bacterial culture
was then transferred into new shake flasks at a density
of 2.5% bacteria into each flask. Different concentrations
of clean PHMB-coated Ag NPs were then added in trip-
licate starting from 0.075 to 0.15 μg/mL of Ag NPs (dif-
ferent tested concentrations of Ag NPs were 0.075, 0.09,
0.1, 0.12, 0.135, and 0.15 μg/mL) into shake flasks just
before inoculating with E. coli. Same concentrations of
Ag NPs were also added into the LB media for the pur-
pose of control experiment to serve as a blank while
measuring their OD at 600 nm. All these shake flasks
containing E. coli strains and Ag NPs, along with con-
trols, were placed in an incubator shaker for 24 h at
37°C at a shaking speed of 150 rpm. The growth of bac-
teria was monitored by measuring OD of samples at
regular intervals at 600 nm. The bacterial growth curves
were then plotted against time based on the data
obtained by carefully monitoring the bacterial growth.
Based on these growth curves, the effect of silver nano-
particles on specific growth rate and doubling time of
E. coli was observed.
Characterization
Transmission electron microscopy of Ag NPs was car-
ried out using a high-resolution transmission electron
microscope (JEOL, JEM-3010, JEOL Ltd., Akishima,
Tokyo, Japan) operating at 300 kV. Nanoparticle speci-
mens, for inspection by transmission electron micros-
copy, were prepared by slow evaporation of one drop of
a dilute aqueous solution of the particles on a carbon-
coated copper mesh grid. ImageJ software was used to
calculate the particle size distribution from transmission
electron micrographs. The particle size distribution and
surface potential of nanoparticles were determined using
Zetasizer Nano ZS (Malvern Instruments, Westborough,
MA, USA). The surface chemistry of Ag NPs was deter-
mined using Bruker Alpha-P FTIR (Bruker Optik Gmbh,
Ettlingen, Germany) with a diamond ATR attachment.
UV-visible spectrum of Ag NPs suspension was recordedusing an Agilent 8453 UV-visible spectrophotometer
(Agilent Technologies Inc., Santa Clara, CA, USA). The
approximate concentration of Ag NPs was determined
using fast sequential atomic absorption spectrometer
(AA240FS) by Varian Inc., Palo Alto, CA, USA.
Results and discussion
Antimicrobial activity of Ag NPs is well known and is
believed to be dependent on the size [21,22], shape
[5,23,24], surface bound ligands [25,26], and their subse-
quent surface charge [44]. Recently, it was reported that
the surface charge of Ag NPs is the most important fac-
tor in this regard while studying the effect of neutral,
positively, and negatively charged Ag NPs on the growth
of gram-positive bacteria belonging to bacillus species
[44]. Negatively charged Ag NPs were found to be the
most effective to retard the growth of these bacteria. In
this study, we have prepared Ag NPs which are posi-
tively charged and, in addition, are functionalized with a
known antimicrobial agent, PHMB, to enhance the anti-
microbial properties of Ag NPs towards gram-negative
bacteria.
Since smaller Ag NPs are considered to have higher
antimicrobial activity [21,22], we produced Ag NPs using
borohydride-reduction method in the presence of
PHMB. The so-formed particles were fairly uniform as
indicated by their narrow surface plasmon resonance
(SPR) bands shown in Figure 2. The size of Ag NPs,
however, varied a bit by varying the concentration of
PHMB, and the most uniform nanoparticles were
obtained using 15 mL of 20 μg/mL PHMB, while keep-
ing other reaction conditions constant, as indicated by
their narrowest SPR band (Figure 2). Using lesser con-
centration of PHMB, the yield of nanoparticles
Figure 3 Transmission electron micrograph of PHMB-stabilized silver nanoparticles (a) and the histogram of their size distribution (b).
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by a decrease in the intensity and broadening of their
SPR bands. By increasing the concentration of PHMB,
the PHMB-Ag complex precipitated forming a milky
suspension before the addition of reducing agent. Trans-
mission electron micrographs of Ag NPs under optimum
conditions, shown in Figure 3a, show that they are fairly
round and uniform in size. In order to calculate the size
and size dispersity of Ag NPs, we measured the size of
at least 300 particles using an ImageJ program, and their
histogram shows that about 75% of these particles are in
the size range ca. 5 to 9 nm (Figure 3b). Dynamic light
scattering (DLS) characterization showed that the major-
ity of the particles were of ca. 60 to 140 nm in size (see
in Additional file 1: Figure S1). The larger size is because
DLS measures the hydrodynamic diameter of the parti-
cles which includes the size of the capping ligands and
the solvent shell.Figure 4 FTIR spectra of PHMB (a) and PHMB-stabilized silver
nanoparticles (b).After the formation of Ag NPs, they were purified
using ultracentrifugation filters to ensure the complete
removal of excess PHMB. The complete removal of ex-
cess PHMB was confirmed by analyzing the filtrate using
FTIR spectroscopy, and centrifuge filtration was
repeated unless no characteristic IR transmission peaks
of PHMB were observed. In order to confirm that
PHMB remains bound to the clean nanoparticles' sur-
face, we measured the surface potential of clean particles
which was found to be +53 mV indicating the presence
of positively charged PHMB on nanoparticles' surface
(see in Additional file 1: Figure S2). In order to further
confirm the functionalization of silver nanoparticles with
PHMB, they were characterized using FTIR spectros-
copy which is a valuable tool to characterize various
functional groups in organic molecules. PHMB shows
sharp spectral peaks between 1,200 and 1,700 cm−1 as
shown in its FTIR spectrum (Figure 4). Its strongFigure 5 Effect of the concentration of PHMB-stabilized silver
nanoparticles on the growth of E. coli.
Table 1 Effect of concentrations of silver nanoparticles
Concentration of Ag NPs in E. coli culture (μg/mL) Specific growth rateμ (h-1) Doubling timetd (h)
0 0.92 ± 0.03 0.75 ± 0.02
0.075 0.25 ± 0.01 2.8 ± 0.01
0.090 0.20 ± 0.01 3.4 ± 0.01
0.100 0.197± 0.01 3.52 ± 0.01
0.120 0.18 ± 0.01 4.31 ± 0.01
0.135 0.15 ± 0.01 4.6 ± 0.01
0.150 0.11 ± 0.01 6.3 ± 0.02
PHMB alone (3 μg/mL) 0.788± 0.03 0.879± 0.02
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PHMB-modified Ag NPs indicating the interaction of
imine groups of PHMB with the nanoparticles.
After confirming the presence of PHMB on the sur-
face of clean Ag NPs, we set out to determine their anti-
microbial activity. Ag NPs are well known for their
antimicrobial activity, and their bacteriostatic and bac-
tericidal concentrations are usually found in the range
of 5 and 50 μg/mL, respectively [5,7,25,45-50]. In order
to improve the antimicrobial activity and broaden its
spectrum, we conjugated Ag NPs with an antimicrobial
agent, PHMB. PHMB, if used alone, shows bactericidal
activity beyond 10 μg/mL [38]. The bacteriostatic and
bactericidal activities of PHMB-functionalized Ag NPs
were, however, improved to be 0.075 and 0.150 μg/mL,
respectively.
Figure 5 shows the growth curves of E. coli in the ab-
sence and presence of varying concentrations (0.075 to
0.15 μg/mL) of PHMB-functionalized Ag NPs. It is evi-
dent from these growth curves that E. coli was unable to
grow for about 10 h even in the presence of the lowest
concentration (0.075 μg/mL) of PHMB-functionalized
Ag NPs used. Even after 10 h, the growth rate was very
slow, and the total bacterial biomass produced after 24 h
was less than one third of that produced in control ex-
periment containing no Ag NPs. The bacterial biomass
was estimated by taking optical density of the samples
withdrawn at regular intervals during bacterial growth.
The growth curves also indicate that E. coli was unable
to grow in the presence of 0.15 μg/mL or higher concen-
tration of PHMB-functionalized Ag NPs even after 24 h.
At this bactericidal concentration of Ag NPs, the black
aggregates of E. coli were clearly visible floating in the
growth media showing the aggregation of bacteria. The
aggregation of bacteria at bactericidal concentration of
many antimicrobial agents is already known and is usu-
ally attributed to the charge neutralization of bacterial
cell's surface in case of PHMB [24]. These results thus
show more than 100 times increase in the bacteriostatic
and bactericidal activities of these cationic Ag NPs com-
pared to the previous reports on Ag NPs. It is worthnoticing that PHMB, when used alone (3 μg/mL) as a
control, had no significant effect on the trend of bacter-
ial growth which is in accordance with the previous find-
ing [38].
Based on the bacterial growth in the presence and ab-
sence of PHMB-functionalized Ag NPs, the specific
growth rate (increase in cell mass per unit time, μ (per
hour)) and doubling time td (hours) for E. coli were also
calculated (Table 1). It is evident from the values of spe-
cific growth rate and doubling time for E. coli that
maximum specific growth rate (0.92 ± 0.03 h−1) and
minimum doubling time (0.75 ± 0.02 h) were observed
in the absence of functionalized Ag NPs. However, the
specific growth rate was decreased and doubling time
increased by increasing the concentration of PHMB-
functionalized Ag NPs. In the presence of PHMB alone
(3 μg/mL), the effect on the specific growth rate and
doubling time of E. coli was not much significant as
shown in Table 1.Conclusions
To summarize, a cationic biocide (PHMB) was used for
the synthesis of fairly uniform silver nanoparticles. The
cationic silver particles thus formed showed much
higher antibacterial activity against E. coli than the previ-
ous reports. PHMB is routinely used in textile industry
due to its antimicrobial activity and affinity to the cellu-
lose fabrics. Therefore, these PHMB-coated silver nano-
particles with enhanced antimicrobial activity may have
very useful applications in textile industry.Additional file
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